Comments
Loading...
Grace Therapeutics (NASDAQ:GRCE) Stock, Earnings Estimates, EPS, And Revenue
Grace Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 25
EPS Estimate
$-0.450
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Grace Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Grace Therapeutics (GRCE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Grace Therapeutics (GRCE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Grace Therapeutics (NASDAQ:GRCE) reporting earnings?
Grace Therapeutics (GRCE) is scheduled to report earnings on February 25, 2025. The last reported earnings were for reported on November 13, 2024 for Q2.
What were the latest earnings per share (EPS) for Grace Therapeutics (NASDAQ:GRCE)?
The Actual EPS was $-0.30, which missed the estimate of $0.00.
What were Grace Therapeutics’s (NASDAQ:GRCE) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.